Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|March 1, 2003
- Volume 0 0
Increased Stroke Risk
Advertisement
Type 2 diabetes has long been associated with an increased risk of stroke, but until recently a connection between stroke and type 1 diabetes had not been established. Now a 17-year study of 23,751 patients with type 1 diabetes has found that the risk of stroke is 5 times greater among men between 20 and 39 years of age and 7 times greater among women in that age group. Published in Stroke, the study author says that its findings ?emphasize the vital need to identify and treat known cardiovascular risk factors in young people with diabetes.?
Articles in this issue
over 23 years ago
Compounding a hydroxyurea liquidover 23 years ago
Does "HC" mean "hydrophilic cream"?over 23 years ago
A Vision for Pharmacy and How to Get There?Part 1over 23 years ago
Humira (adalimumab, D2E7)over 23 years ago
Drug Diversion Versus Pain Management?Part 1over 23 years ago
Pharmacy Pays Dearly After Misleading Courtover 23 years ago
Becoming a Culturally Competent Pharmacistover 23 years ago
Is There a Vaccine in Your Future?over 23 years ago
Growing Professionally with a MentorAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
4
Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds
5